Dow Up 0.11% Nasdaq Up 0.50%

Transcept Pharmaceuticals, Inc. (TSPT)

-NasdaqGM
2.20 Down 0.01(0.45%) Aug 29, 3:59PM EDT
|After Hours : 2.20 0.00 (0.00%) Aug 29, 4:01PM EDT
Prev Close:2.21
Open:2.20
Bid:0.17 x 100
Ask:2.28 x 9100
1y Target Est:4.20
Beta:-0.27
Earnings Date:Nov 5 - Nov 10 (Est.)
Day's Range:2.17 - 2.24
52wk Range:1.85 - 3.90
Volume:135,673
Avg Vol (3m):216,566
Market Cap:42.15M
P/E (ttm):N/A
EPS (ttm):-1.05
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for TSPT

Comparison

Symbol% ChgMkt Cap
TSPTDown 0.45%42.15M
APRIUp 0.53%72.39M
PTIEUp 0.24%193.09M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):31.65
Ex-Dividend Date:04-Jun-14

Analysts

Annual EPS Est (Dec-14) :N/A
Quarterly EPS Est (Sep-14) :N/A
Mean Recommendation*:3.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Transcept Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of proprietary products that address therapeutic needs in the field of neuroscience. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback